These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22883696)

  • 1. WHO guideline development of paediatric medicines: points to consider in pharmaceutical development.
    Kristensen HG
    Int J Pharm; 2012 Oct; 435(2):134-5. PubMed ID: 22883696
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Packaging of medicines for paediatric use: Prescrire's constructive proposals.
    Prescrire Int; 2012 Oct; 21(131):249-50. PubMed ID: 23185854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EMA quality guideline on the pharmaceutical development of medicines for paediatric use.
    van Riet-Nales DA; Wang S; Saint-Raymond A; Robert JL
    Int J Pharm; 2012 Oct; 435(2):132-4. PubMed ID: 22883695
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances.
    Humfrey CD
    Toxicol Sci; 2007 Nov; 100(1):24-8. PubMed ID: 17656486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting commentary--formulating better medicines for children.
    Hempenstall J; Tuleu C
    Int J Pharm; 2009 Sep; 379(1):143-5. PubMed ID: 19576979
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of "inert" additives or excipients in paediatric medicines.
    Nahata MC
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
    [No Abstract]   [Full Text] [Related]  

  • 10. International initiatives on extemporaneous dispensing.
    Nunn A; Aindow A; Woods D
    Int J Pharm; 2012 Oct; 435(2):135-7. PubMed ID: 22883697
    [No Abstract]   [Full Text] [Related]  

  • 11. Advanced microscopy techniques to assess solid-state properties of inhalation medicines.
    Shur J; Price R
    Adv Drug Deliv Rev; 2012 Mar; 64(4):369-82. PubMed ID: 22120022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO wants safer medicines for children.
    Choonara I
    Arch Dis Child; 2008 Jun; 93(6):456-7. PubMed ID: 18495908
    [No Abstract]   [Full Text] [Related]  

  • 13. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
    J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety issues with ethanol as an excipient in drugs intended for pediatric use.
    Zuccotti GV; Fabiano V
    Expert Opin Drug Saf; 2011 Jul; 10(4):499-502. PubMed ID: 21417862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.
    Salunke S; Liu F; Batchelor H; Walsh J; Turner R; Ju TR; Tuleu C;
    AAPS PharmSciTech; 2017 Feb; 18(2):257-262. PubMed ID: 27422653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.